IGMS - igmbio.com Projected Sales Volume

IGM Biosciences, Inc. (IGMS) - corporate logo

IGM Biosciences, Inc. (IGMS) is developing unique IgM antibody-based medicines, laying the foundation for future partner payments. The projected sales volume illustrates the market response to these achievements, where the current status is 0.15. Its own cGMP facility in California ensures stability. Meanwhile, the potential in treating autoimmune pathologies is only beginning to emerge, and the liquidity for research is already priced into the quotes.

IGMS - IGM Biosciences, Inc. Company Future Sales over the range 07/04/2022 - 08/24/2025

Metric breakdowns and analytics for IGM Biosciences (IGMS)

- stock value and consensus price forecast:
Fundamental valuation:IGM Bio
Signature product of igmbio.com

This indicator identifies systemic degradation or business growth potential, eliminating the illusion of an undervalued asset. Analyzing the company's projected sales allows for a comparison of market demand against actual logistical costs. The calculation is based on the extrapolation of current commercial prospects and expected revenue. This is critical for IGM Biosciences, Inc. (IGMS), as it monetizes colossal R&D expenditures on the development of IgM antibodies. The metric confirms the long-term efficiency of the proprietary platform.

Competing companies

Company Projected Revenue Argenx (ARGX)|BioNTech - Company Revenue Forecast|Projected Sales Volume ABVX (Abivax)|ADMA Bio (ADMA) - Company Expected Sales Volume|PTGX - Company Projected Revenue|Company Future Sales immunovant.com IMVT|KNSA: Projected Sales Volume|Grifols - Company Future Revenue|ADPT (Adaptive Biotech) - Projected Sales Volume|Company Projected Revenue CLDX|Projected Sales Volume AUPH|Company Future Sales Volume biocryst.com BCRX|Vera Therapeutics - Company Future Sales Volume|Company Projected Revenue Volume DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV - Projected Sales Volume|ABCL: Company Projected Revenue|Tourmaline Bio, Inc. (TRML) - Company Projected Revenue|Company Expected Sales Volume precigen.com (PGEN)|PHAR (pharming.com) - Projected Sales Volume|NKTR (Nektar Therapeutics Inc.) - Company Projected Revenue Volume|Projected Sales Volume UPB|ZBIO - Company Expected Sales Volume|Projected Sales Volume IMNM (immunome.com)|Gossamer Bio, Inc. - Company Projected Revenue|KalVista Pharmaceuticals, Inc. - Projected Sales Volume|SEPN (Septerna) - Company Revenue Forecast|Pieris Corp (PVLA) - Company Projected Revenue|SVRA - Company Future Sales|RIGL (rigel.com) - Projected Sales Volume|Company Revenue Forecast ANAB (AnaptysBio, Inc.)|Projected Sales Volume ATXS|enGene Holdings Inc (ENGN) - Company Sales Forecast|Projected Sales Volume RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Company Expected Revenue|ACRS: Company Future Sales Volume|KYTX - Projected Sales Volume|TLSA: Projected Sales Volume|Company Future Sales Volume Cabaletta Bio, Inc|Company Projected Revenue Ventyx Biosciences, Inc|THTX: Company Future Revenue|Company Future Sales Volume AVTX (Avalo Therapeutics, Inc)|Company Future Sales Volume Eledon Pharmaceuticals ELDN|Company Projected Revenue Agenus, Inc. AGEN|Projected Sales Volume Climb Bio Inc. CLYM|ZURA - Company Projected Revenue|Company Expected Revenue ATYR|ADAG (Adagene Inc.) - Company Future Sales Volume|ImageneBio Inc (IMA) - Projected Sales Volume|Company Projected Revenue Shattuck Therapeutics|Company Future Sales Volume equilliumbio.com (EQ)|Projected Sales Volume CNTB|Company Future Sales Immunic Therapeutics|Projected Sales Volume ATRA (Atara Biotherapeutics, Inc.)|IFRX - Company Future Sales Volume|Company Future Revenue X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Company Revenue Forecast|CELU: Projected Sales Volume|INMB - Company Future Sales|Company Projected Revenue Barinthus Biotherapeutics plc|KZR: Company Future Revenue|Projected Sales Volume SABS|AKTX (Akari Therapeutics Plc) - Company Future Revenue|Projected Sales Volume ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Company Projected Revenue|GOVX: Company Future Sales Volume|edesabiotech.com (EDSA) - Company Future Sales Volume|IBIO: Projected Sales Volume|CARM - Company Future Sales|Company Future Sales Volume XTLB|Company Future Sales Volume boltbio.com (BOLT)|Company Projected Revenue HCW Biologics Inc (HCWB)|Projected Sales Volume Aptevo Therapeutics, Inc. (APVO)|Company Projected Revenue aimimmuno.com AIM|Company Future Revenue ADTX|GRI Bio Corporation - Projected Sales Volume|XORTX Corp (XRTX) - Company Future Sales Volume|HIND (Vyome Holdings Inc.) - Company Future Sales Volume|revbiosciences.com (REVB) - Projected Sales Volume|INDP (Indaptus Corp) - Projected Sales Volume|Company Future Sales Volume Scinai Immunotherapeutics Ltd (SCNI)|Company Projected Revenue CalciMedica Inc (CALI)|AFMD (Affimed NV) - Company Future Revenue|Projected Sales Volume ALLK (Allakos Inc.)|Projected Sales Volume HOOKIPA HOOK|ITOS: Company Future Sales Volume|Company Expected Sales Volume Ocean Biomedical|TCBP: Projected Sales Volume|Third Harmonic Bio, Inc - Company Future Revenue